After a month of controversy following the retraction of the Surgisphere paper trashing the drug. But what to do about the op-ed endorsing the views in the paper?:
As questions swirled around the paper, Stuart Spencer, an editor at The Lancet, told Funck-Brentano to wait for the audit — which turned out to be impossible because Surgisphere would not cooperate. The journal’s ethical review committee then contacted Funck-Brentano, letting him know that the paper would be retracted and that the commentary would have to be, too.“A month after Surgisphere paper retraction, Lancet retracts, replaces hydroxychloroquine editorial” at Retraction Watch
The journal received the advice to retract the op-ed and publish a new one, so:
The journal — which, along with the JAMA journals has been using the “retract and replace” approach — agreed to that. Funck-Brentano and his colleague, along with a new co-author, wrote a new version, and it was accepted a few weeks ago.
The retraction and republication appears today. “A month after Surgisphere paper retraction, Lancet retracts, replaces hydroxychloroquine editorial” at Retraction Watch
Beware of internet history. It is written on little electronic signals, not paper…
See also: The big Covid-19 retractions: Top people didn’t notice the smell?